CTSO Cytosorbents Corp

CytoSorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses and cardiac surgery.

$1.39  +0.19 (15.83%)
As of 09/27/2022 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  08/08/2006
Outstanding shares:  43,577,429
Average volume:  135,141
Market cap:   $52,292,915
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BTCB1L1
Valuation   (See tab for details)
PE ratio:   -2.06
PB ratio:   1.09
PS ratio:   2.80
Return on equity:   -52.96%
Net income %:   -156.93%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy